| scholarly article | Q13442814 |
| P50 | author | Louise A. Brinton | Q58623846 |
| Christine Swanson | Q88605932 | ||
| Michael L. Berman | Q97448902 | ||
| Nancy Potischman | Q114515984 | ||
| Robert N. Hoover | Q118558329 | ||
| P2093 | author name string | Barrett RJ | |
| Wilbanks GD | |||
| Persky V | |||
| Dorgan JF | |||
| Lurain JR | |||
| Mortel R | |||
| Twiggs LB | |||
| Siiteri P | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1127-1135 | |
| P577 | publication date | 1996-08-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Case-control study of endogenous steroid hormones and endometrial cancer | |
| P478 | volume | 88 |
| Q37057772 | A large cohort study of hypothyroidism and hyperthyroidism in relation to gynecologic cancers |
| Q55313089 | Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture. |
| Q43643752 | Alcoholism and risk for endometrial cancer |
| Q37381777 | Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology |
| Q44563417 | Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus |
| Q26749272 | Aromatase expression and regulation in breast and endometrial cancer |
| Q83202993 | Association between adiponectin, insulin resistance, and endometrial cancer |
| Q37001517 | Association between the CYP11 family and six cancer types |
| Q37347070 | Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women. |
| Q39787508 | Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene. |
| Q34700054 | Association of genetic markers in the BCL-2 family of apoptosis-related genes with endometrial cancer risk in a Chinese population |
| Q34958461 | Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women |
| Q91780489 | Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling |
| Q43930956 | CYP17 genetic polymorphism in endometrial cancer: are only steroids involved? |
| Q64891209 | Cancer Progress and Priorities: Uterine Cancer. |
| Q39037694 | Clinical implications of estrone sulfate measurement in laboratory medicine |
| Q33829174 | Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes |
| Q35450748 | Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: a prospective cohort study. |
| Q37328112 | Dietary fat intake and endometrial cancer risk: A dose response meta-analysis |
| Q35659602 | Dietary fat, fiber, and carbohydrate intake and endogenous hormone levels in premenopausal women |
| Q34949960 | Dietary fat, fiber, and carbohydrate intake in relation to risk of endometrial cancer |
| Q37012730 | Dietary lipids and endometrial cancer: the current epidemiologic evidence |
| Q33700344 | Differences in ovarian hormones in relation to parity and time since last birth. |
| Q37057923 | Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma. |
| Q44601614 | Direct immunoassay of estrone by capillary electrophoresis with laser‐induced fluorescence detection |
| Q36493879 | Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases |
| Q36676316 | Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). |
| Q95806002 | Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers |
| Q63199203 | Endometrial cancer |
| Q28376683 | Endometrial cancer after combined hormone replacement therapy |
| Q34978586 | Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship |
| Q33894510 | Enhanced estrogen-induced proliferation in obese rat endometrium |
| Q38788210 | Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences |
| Q60949505 | Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma |
| Q38205851 | Estrogenic endocrine-disrupting chemicals: molecular mechanisms of actions on putative human diseases |
| Q77441863 | Evolving concepts in endometrial carcinogenesis: importance of DNA repair and deregulated growth |
| Q34556688 | Expression of genes encoding extracellular matrix proteins: a macroarray study. |
| Q46825192 | Genetic variation in CYP17 and endometrial cancer risk |
| Q37454788 | Genetic variation in the androgen receptor gene and endometrial cancer risk |
| Q33781274 | Genetics of endometrial cancers |
| Q34522434 | Green and black tea in relation to gynecologic cancers |
| Q33541943 | Hormonal treatment of endometrial cancer. |
| Q47399735 | Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature |
| Q26825204 | In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production |
| Q37812784 | Inhibition of estrogen actions in human gynecological malignancies: New aspects of endocrine therapy for endometrial cancer and ovarian cancer |
| Q54379484 | Insulin exerts direct effects on carcinogenic transformation of human endometrial organotypic cultures. |
| Q36765152 | Intra-abdominal adipose tissue is independently associated with sex-hormone binding globulin in premenopausal women |
| Q37238537 | Management of endometrial precancers |
| Q33844582 | Maximizing resources to study an uncommon cancer: E2C2--Epidemiology of Endometrial Cancer Consortium. |
| Q36463982 | Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications |
| Q54377413 | Molecular alterations of PI3K/Akt/mTOR pathway: a therapeutic target in endometrial cancer. |
| Q36772096 | Molecular carcinogenesis of endometrial cancer |
| Q35640925 | Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification |
| Q35065032 | Molecular pathogenesis and prognostic factors in endometrial carcinoma |
| Q30454692 | Morbidly obese women with and without endometrial cancer: are there differences in measured physical fitness, body composition, or hormones? |
| Q46425362 | Mortality toll due to avoiding estrogen therapy in hysterectomized women: estimates for 2002 – 2011. |
| Q33703792 | Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice |
| Q39026659 | Obesity and Endometrial Cancer |
| Q50850164 | Obesity as a risk factor for certain types of cancer. |
| Q47839527 | Obesity, body fat distribution and breast cancer |
| Q33684880 | Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort |
| Q38381450 | Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women |
| Q33699606 | Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones |
| Q34826618 | Overweight, obesity, and cancer risk |
| Q38788207 | Pathology of Endometrial Carcinoma |
| Q35562877 | Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women |
| Q36194452 | Polycystic ovary syndrome and gynecological cancers: is there a link? |
| Q28361980 | Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study |
| Q36880019 | Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study |
| Q47597561 | Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer |
| Q34859018 | Prospective evaluation of insulin resistance among endometrial cancer patients |
| Q24310874 | Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress |
| Q37989094 | Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage. |
| Q84551771 | Risk of endometrial cancer in relation to individual nutrients from diet and supplements |
| Q37390358 | Risk of endometrial cancer in relation to medical conditions and medication use. |
| Q34397284 | Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives |
| Q36329913 | Role of metformin in the management of polycystic ovary syndrome |
| Q26771828 | Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers |
| Q34565492 | Roles of androgens in the development, growth, and carcinogenesis of the mammary gland |
| Q44491478 | Serum insulin-like, growth factor binding protein-related protein 1 (IGFBP-rP1) and endometrial cancer risk in Chinese women |
| Q51557446 | Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. |
| Q39366156 | Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature. |
| Q33657348 | Sex hormones and the risk of keratinocyte cancers among women in the United States: A population-based case-control study |
| Q34362820 | Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study |
| Q41476056 | Steroid hormones and cancer: (III) observations from human subjects |
| Q37400657 | The Asp(327)Asn polymorphism in the sex hormone-binding globulin gene modifies the association of soy food and tea intake with endometrial cancer risk |
| Q33809605 | The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers |
| Q41692912 | The association between endometrial polyps and metabolic syndrome: a case-control study. |
| Q43185522 | The association between metabolic abnormality and endometrial cancer: a large case-control study in China |
| Q27026813 | The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms |
| Q37631061 | The endometrium--from estrogens alone to TSECs |
| Q38743681 | The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives. |
| Q82281166 | The identification of two subgroups of obese women with differing endometrial proliferation levels: potential consequences in the development of endometrial cancer |
| Q78390178 | The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer |
| Q44847031 | The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism |
| Q37404662 | The role of estrogen receptor subtypes for vascular maintenance. |
| Q33886758 | Theories of endometrial carcinogenesis: a multidisciplinary approach |
| Q37288861 | Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study |
| Q44403900 | Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer |
| Q37157438 | Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium |
| Q38551472 | Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin |
| Q37196777 | Variants in hormone biosynthesis genes and risk of endometrial cancer |
| Q74441039 | Variation in endometrial thickening in women with amenorrhea on tamoxifen |
| Q30279296 | Women at extreme risk for obesity-related carcinogenesis: Baseline endometrial pathology and impact of bariatric surgery on weight, metabolic profiles and quality of life |
Search more.